| Name | Title | Contact Details |
|---|
Aumenta tus ventas con Melonn ofreciendo entregas el mismo día. Nos conectamos con todos tus canales de ventas. Tú vendes, nosotros entregamos.
At Cambridge, we design and deliver innovative and adaptive solutions to address your capacity-building needs and enable your success. We leverage our expertise and experience in aviation, operations, security, and technology solutions to deliver strat...
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.
BrokerPriceOpinion.com is a Westminster, CO-based company in the Software and Internet sector.
Wahoo Fitness is a fitness technology company based in Atlanta, Georgia.